Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Bio-Rad Laboratories Class A
BIO
$9.66B
| $2.21M | ﹤0.01% |
7,053
+2,784
| +65% | +$864K |
|
2727
Genesis Energy
GEL
$1.92B
| $2.21M | ﹤0.01% |
92,814
-64,812
| -41% | -$1.53M |
|
2728
Portland General Electric
POR
$5.92B
| $2.21M | ﹤0.01% |
48,396
+34,714
| +254% | +$1.58M |
|
|
LCI
2729
PUT
DELISTED
Lannett Company, Inc.
LCI
| $2.2M | ﹤0.01% |
116,025
-127,875
| -52% | -$4.87M |
|
|
CLVS
2730
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.2M | ﹤0.01% |
75,076
-4,640
| -6% | -$180K |
|
2731
CALL
Goodyear
GT
$1.78B
| $2.2M | ﹤0.01% |
94,200
-3,600
| -4% | -$84.6K |
|
2732
Popular Inc
BPOP
$11.3B
| $2.2M | ﹤0.01% |
42,963
+31,130
| +263% | +$1.55M |
|
2733
CALL
Canadian Natural Resources
CNQ
$98.1B
| $2.2M | ﹤0.01% |
137,631
-297,111
| -68% | -$5.03M |
|
|
MANT
2734
DELISTED
Mantech International Corp
MANT
| $2.2M | ﹤0.01% |
34,771
+11,674
| +51% | +$727K |
|
2735
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.33B
| $2.19M | ﹤0.01% |
20,300
+20,033
| +7,503% | +$2.15M |
|
2736
Empire State Realty Trust
ESRT
$836M
| $2.19M | ﹤0.01% |
131,965
-321,970
| -71% | -$5.49M |
|
|
CTLT
2737
DELISTED
CATALENT, INC.
CTLT
| $2.19M | ﹤0.01% |
48,105
-96,204
| -67% | -$4.06M |
|
|
HT
2738
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $2.19M | ﹤0.01% |
96,572
+28,388
| +42% | +$636K |
|
|
UFS
2739
DELISTED
DOMTAR CORPORATION (New)
UFS
| $2.19M | ﹤0.01% |
41,973
+8,970
| +27% | +$452K |
|
2740
Wayfair
W
$13.9B
| $2.19M | ﹤0.01% |
14,803
-86,240
| -85% | -$11M |
|
|
MINI
2741
DELISTED
Mobile Mini Inc
MINI
| $2.19M | ﹤0.01% |
49,805
+33,495
| +205% | +$1.49M |
|
2742
Madison Square Garden
MSGS
$9.94B
| $2.18M | ﹤0.01% |
9,716
+7,295
| +301% | +$1.62M |
|
2743
Wyndham Hotels & Resorts
WH
$5.51B
| $2.18M | ﹤0.01% |
39,315
-185,585
| -83% | -$10.6M |
|
|
HIMX
2744
PUT
Himax Technologies
HIMX
$2.56B
| $2.18M | ﹤0.01% |
371,100
+53,000
| +17% | +$352K |
|
2745
World Kinect Corp
WKC
$1.9B
| $2.18M | ﹤0.01% |
78,771
+23,464
| +42% | +$602K |
|
|
UNT
2746
DELISTED
UNIT Corporation
UNT
| $2.18M | ﹤0.01% |
83,648
+64,003
| +326% | +$1.66M |
|
2747
CALL
Liberty Global Class A
LBTYA
$3.58B
| $2.18M | ﹤0.01% |
75,200
+1,800
| +2% | +$50.2K |
|
2748
CALL
Weibo
WB
$1.88B
| $2.18M | ﹤0.01% |
29,760
-15,700
| -35% | -$1.26M |
|
2749
PUT
Parker-Hannifin
PH
$134B
| $2.17M | ﹤0.01% |
11,800
-4,800
| -29% | -$825K |
|
|
2750
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $2.17M | ﹤0.01% |
37,000
+18,800
| +103% | +$1.07M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.